houttuynia
cordata
polysaccharid
hcp
extract
houttuynia
cordata
key
tradit
chines
medicin
studi
investig
effect
hcp
intestin
barrier
microbiota
viru
infect
mice
mice
infect
viru
oral
administr
hcp
dosag
infect
caus
pulmonari
intestin
injuri
gut
microbiota
imbal
hcp
significantli
suppress
express
hypoxia
induc
decreas
mucosubst
goblet
cell
restor
level
zonula
intestin
hcp
also
revers
composit
chang
intestin
microbiota
caus
infect
significantli
reduc
rel
abund
vibrio
bacillu
pathogen
bacteri
genera
furthermor
hcp
rebalanc
gut
microbiota
restor
intestin
homeostasi
degre
inhibit
inflamm
associ
reduc
level
tolllik
receptor
intestin
well
increas
product
oral
administr
hcp
allevi
lung
injuri
intestin
dysfunct
caus
infect
hcp
may
gain
system
treatment
local
act
intestin
microbiota
studi
prove
highvalu
applic
hcp
key
word
influenza
viru
houttuynia
cordata
inflamm
intestin
barrier
microbiota
polysaccharid
clc
number
document
code
articl
id
author
contribut
work
equal
author
conflict
interest
declar
publish
elsevi
bv
right
reserv
influenza
infecti
diseas
caus
influenza
viru
fatal
infect
relat
pneumonia
character
massiv
lung
inflamm
result
damag
tissu
demonstr
influenza
viru
infect
caus
lung
injuri
also
intestin
structur
damag
therebi
lead
gastroenteritislik
symptom
clinic
gastrointestin
symptom
includ
abdomin
pain
nausea
vomit
diarrhea
often
occur
influenza
intestin
damag
impair
intestin
mucos
barrier
system
barrier
mainli
compos
mechan
barrier
chemic
barrier
immun
barrier
biolog
barrier
mechan
barrier
includ
intact
intestin
epitheli
cell
intercellular
tight
junction
includ
occludin
zonula
disrupt
hypoxia
induc
activ
chemic
barrier
mainli
consist
mucu
secret
goblet
cell
induct
goblet
cell
mucin
secret
occur
frequent
acut
phase
intestin
injuri
immun
barrier
consist
factor
immunoglobulin
iga
intramucos
lymphocyt
mesenter
lymph
node
immun
barrier
associ
mechan
barrier
chemic
barrier
form
import
line
defens
virus
invas
bacteria
iga
defici
relat
mild
intestin
microbiota
dysbiosi
disturb
bacteri
depend
network
normal
gut
microbiota
particip
digest
absorpt
metabol
host
constitut
biolog
barrier
prevent
invas
harm
substanc
divers
health
intestin
microbiota
help
protect
influenza
infect
host
affect
advers
intestin
barrier
impair
polysaccharid
ink
ommastreph
bartrami
opb
restor
express
level
tight
junction
protein
occludin
also
opb
chang
intestin
microflora
composit
moreov
potenti
therapi
mechan
polysaccharid
ganoderma
lucidum
strain
chronic
pancreat
might
intestin
microbiota
depend
specul
regul
intestin
barrier
microbiota
oral
administr
polysaccharid
may
benefici
effect
reliev
influenza
symptom
houttuynia
cordata
polysaccharid
hcp
extract
houttuynia
cordata
herb
serv
key
tradit
chines
medicin
pneumonia
treatment
antivir
antiinflammatori
antibacteri
antiprolif
activ
houttuynia
cordata
demonstr
mani
research
previou
studi
prove
hcp
reduc
acut
lung
inflammatori
injuri
caus
lp
vivo
amelior
pulmonari
inflammatori
injuri
caus
infect
via
inhibit
pathway
activ
proinflammatori
cytokin
express
found
previou
studi
hcp
strengthen
intestin
barrier
mice
significantli
increas
iga
intestin
nevertheless
indepth
research
carri
effect
mechan
hcp
intestin
infect
mous
model
use
studi
effect
hcp
intestin
barrier
especi
intestin
microbiota
infect
studi
demonstr
hcp
allevi
intestin
barrier
damag
gut
inflamm
improv
intestin
microbiota
homeostasi
hcp
may
reduc
pulmonari
injuri
caus
infect
exert
activ
intestin
microbiota
result
prove
high
valu
hcp
treatment
influenza
mouseadapt
strain
high
pathogen
influenza
viru
suppli
dr
zhu
haiyan
school
pharmaci
fudan
univers
shanghai
china
store
freshli
thaw
experi
hcp
suppli
dr
chen
daofeng
school
pharmaci
fudan
univers
shanghai
china
previous
report
hcp
compris
total
carbohydr
mainli
compos
glc
gal
ara
rha
ratio
along
trace
man
xyl
reagent
includ
ribavirin
rib
weebeyonnd
scientif
trade
co
ltd
rpmi
medium
solarbio
anti
antibodi
proteintech
group
inc
goat
antirabbit
igg
h
l
hrp
antibodi
bioworld
technolog
inc
alcian
blue
tri
sinopharm
chemic
reagent
co
ltd
period
acid
solut
schiff
reagent
baso
biotechnolog
co
ltd
anti
antibodi
abcam
co
ltd
dab
buffer
shanghai
rong
xin
biotechnolog
co
ltd
tianamp
stool
dna
kit
tiangen
biotech
co
ltd
truseq
dna
sampl
prepar
kit
illumina
miseq
illumina
ripa
lysi
buffer
proteas
inhibitor
sdspage
gel
parpar
kit
tween
beyoecl
plu
kit
elisa
kit
beyotim
biotechnolog
co
ltd
polyvinyliden
fluorid
membran
millipor
elisa
kit
boatman
biotechnolog
co
ltd
male
balbc
mice
week
obtain
shanghai
slacca
lab
anim
co
ltd
spf
ii
certif
mice
randomli
divid
four
experiment
group
n
normal
model
dosag
hcp
ribavirin
rib
accord
research
paper
protocol
use
experi
approv
anim
ethic
committe
school
pharmaci
fudan
univers
identif
intranas
instil
cultur
medium
normal
group
influenza
viru
dose
perform
intraven
anesthesia
propofol
treatment
initi
h
challeng
last
day
cmc
medicin
administ
oral
gavag
mice
sacrif
euthanasia
day
harvest
lung
intestin
tissu
left
lobe
lung
small
intestin
fix
immedi
phosphat
buffer
formalin
solut
ph
histolog
evalu
cecum
content
collect
store
dna
isol
late
evalu
sever
pneumonia
lung
section
cut
stain
haematoxylin
eosin
h
e
briefli
clear
paraffin
sampl
held
glass
slide
xylen
sampl
hydrat
stain
hematoxylin
solut
slide
place
run
tap
water
follow
stain
sampl
work
eosin
solut
final
dehydr
sampl
clear
xylen
intestin
section
stain
alcian
blueperiod
acidschiff
abpa
detect
mucosubst
goblet
cell
immunohistochem
stain
carri
method
describ
articl
antigen
retriev
endogen
peroxidas
remov
nonspecif
bind
site
block
lung
tissu
incub
antibodi
antibodi
intestin
section
incub
antibodi
antibodi
overnight
follow
wash
pb
incub
hrpconjug
antibodi
min
water
bath
slice
visual
use
dab
chromogen
substrat
solut
observ
microscop
averag
iod
valu
four
field
per
slide
measur
imagej
statist
analysi
late
averag
iod
integr
optic
densiti
iod
area
base
research
report
microbi
genom
dna
extract
sampl
cecum
content
use
tianamp
stool
dna
kit
success
isol
dna
confirm
agaros
gel
electrophoresi
hypervari
region
rdna
pcr
amplifi
use
fusion
primer
forward
primer
revers
primer
pcr
condit
follow
one
predenatur
cycl
min
cycl
denatur
anneal
elong
one
postelong
cycl
min
pcr
amplicon
product
separ
extract
agaros
gel
pcr
product
use
construct
sequenc
librari
use
truseq
dna
sampl
prepar
kit
amplicon
product
sequenc
illumina
miseq
sequenc
assembl
trim
taxondepend
analysi
conduct
use
greengen
databas
releas
http
greengenessecondgenomecom
distribut
plot
speci
phylum
level
gener
qiim
relativeabund
analysi
intestin
microbiota
genu
level
perform
stamp
http
kiwicsdalcasoftwarestamp
alpha
divers
index
includ
index
ace
index
shannon
index
index
ace
index
reflect
rich
shannon
index
estim
rich
commun
even
calcul
mothur
softwar
version
http
wwwmothurorg
beta
divers
analysi
calcul
qiim
accord
result
threedimension
princip
coordin
analysi
pcoa
plot
nonmetr
multidimension
scale
nmd
plot
made
heatmap
implement
r
pheatmap
softwar
microbi
function
predict
use
picrust
describ
report
gene
function
align
kegg
databas
data
analysi
perform
softwar
stamp
intestin
protein
prepar
use
ripa
lysi
buffer
supplement
proteas
inhibitor
protein
separ
sodium
dodecyl
sulfatepolyacrylamind
gel
electrophoresi
sdspage
transfer
polyvinyliden
fluorid
pvdf
membran
membran
block
nonfat
milk
min
incub
primari
antibodi
overnight
membran
incub
hrplabel
secondari
antibodi
h
room
temperatur
wash
trisbuff
salin
tween
tbst
band
visual
use
beyoecl
plu
kit
intestin
homogen
prepar
concentr
mg
tissueml
pb
total
protein
concentr
determin
level
intestin
homogen
assay
use
enzym
link
immunosorb
assay
elisa
kit
accord
manufactur
instruct
result
express
mean
standard
deviat
sd
oneway
anova
fisher
lsd
test
chosen
multipl
comparison
statist
analyz
intestin
microbiota
anova
test
appli
tukeykram
post
hoc
test
benjaminihochberg
fdr
multipl
test
correct
p
consid
statist
signific
lung
tissu
infect
mice
show
inflammatori
injuri
mainli
character
red
blood
cell
leakag
monocyt
lymphocyt
infiltr
thicken
alveolar
wall
fig
hcp
rib
treatment
minim
patholog
chang
express
lung
normal
mice
concentr
nucleu
distribut
insid
outsid
nucleu
model
group
fig
efficaci
hcp
evid
reduc
releas
nucleu
fig
fig
infect
significantli
increas
express
downregul
hcp
fig
fig
patholog
injuri
intestin
villi
swell
occur
mice
infect
wherea
hcp
effect
attenu
patholog
chang
fig
hypoxia
induc
may
caus
loss
tight
junction
protein
result
show
intens
immunostain
express
intestin
tissu
model
group
fig
fig
compar
model
group
hcp
rib
group
exhibit
rel
low
level
stain
zonula
one
kind
tight
junction
protein
particip
format
mechan
barrier
protein
express
reduc
mice
infect
viru
fig
fig
hcp
rib
treatment
markedli
improv
express
mucosubst
goblet
cell
infect
mice
mice
normal
hcp
treat
group
fig
fig
phylum
level
infect
decreas
rel
abund
bacteroidet
firmicut
increas
rel
abund
proteobacteria
planctomycet
chloroflexi
actinobacteria
fig
hcp
treatment
revers
chang
genu
level
rel
abund
vibrio
fig
mycobacterium
fig
bacillu
fig
campylobact
fig
higher
viru
infect
mice
comparison
normal
mice
hcp
rib
given
oral
significantli
decreas
rel
abund
vibrio
bacillu
rel
abund
mycobacterium
campylobact
detect
limit
rib
treatment
group
although
statist
signific
group
slightli
higher
index
ace
index
other
tabl
shannon
index
model
group
mildli
higher
normal
group
group
group
weight
analysi
unifrac
pcoa
fig
nmd
fig
show
clear
separ
model
group
group
commun
differ
normal
group
group
minim
percentag
pcoa
respect
heatmap
genu
sampl
show
fig
genu
normal
group
differ
group
differ
normal
group
model
group
obviou
intestin
content
model
group
contain
microbi
function
gene
normal
group
metabol
amino
acid
fig
energi
fig
lipid
fig
fewer
function
gene
enzym
metabol
fig
hcp
rib
treatment
revers
chang
addit
show
intestin
microbiom
model
group
rel
abund
function
gene
associ
cancer
fig
cardiovascular
diseas
fig
infecti
diseas
fig
neurodegen
diseas
fig
increas
hcp
rib
treatment
decreas
rel
abund
function
gene
result
western
blot
show
infect
significantli
increas
express
intestin
fig
hcp
rib
downregul
express
shown
fig
fig
infect
led
strong
increas
product
caus
signific
decreas
product
intestin
hcp
rib
significantli
inhibit
product
addit
hcp
markedli
promot
product
concentr
slightli
higher
mice
treat
rib
compar
infect
mice
statist
signific
studi
mice
infect
viru
show
clinic
sign
poor
appetit
signific
declin
weight
day
also
symptom
hypergasia
diarrhea
unform
fece
oral
administr
hcp
amelior
weight
loss
diarrhea
infect
lead
lung
injuri
character
red
blood
cell
leakag
monocyt
lymphocyt
infiltr
thicken
alveolar
wall
addit
infect
caus
increas
high
mobil
group
box
protein
level
seen
lung
tissu
tlr
signal
pathway
activ
belong
damag
associ
molecular
pattern
damp
found
increas
express
lung
infect
mice
studi
demonstr
hcp
reduc
express
lung
contribut
allevi
lung
injuri
caus
infect
lung
respiratori
organ
lung
damag
undoubtedli
result
impair
ga
exchang
lead
system
hypoxia
protect
major
organ
bodi
redistribut
blood
intestin
organ
caus
gut
ischemia
hypoxia
upregul
hypoxia
induc
protein
induc
hypoxia
inflamm
infect
may
caus
loss
tight
junction
protein
goblet
cell
mucu
well
iga
essenti
intestin
barrier
integr
impair
chang
factor
result
harm
substanc
like
lp
bacteria
normal
locat
digest
tract
might
invad
tissu
give
rise
inflamm
combin
present
result
previou
studi
destruct
intestin
barrier
infect
character
chang
mucosubst
iga
intestin
hcp
significantli
revers
chang
factor
restor
gut
barrier
thu
hcp
might
abl
reduc
transloc
bacteria
transport
harm
substanc
blood
allevi
inflammatori
injuri
recent
found
pathogen
introduc
respiratori
system
give
rise
intestin
dysfunct
intestin
dysbiosi
affect
lung
immun
respons
gutlung
axi
theori
rais
describ
close
relat
two
organ
emerg
evid
present
modulatori
role
gut
microbiota
elicit
immun
respons
influenza
demonstr
regul
intestin
microbiota
potenti
treatment
lung
diseas
studi
show
intestin
microbiota
serv
protect
mediat
host
defens
pneumococc
pneumonia
composit
commens
microbiota
influenc
gener
virusspecif
cell
initi
adapt
immun
follow
influenza
viru
infect
therefor
intestin
especi
intestin
microbiota
vital
immun
regul
respons
viral
pneumonia
studi
rel
abund
commonli
repres
bacteri
phyla
includ
firmicut
bacteroidet
actinobacteria
proteobacteria
chang
viru
infect
reflect
perturb
hcp
treatment
revers
composit
chang
markedli
diminish
rel
abund
vibrio
bacillu
belong
pathogen
bacteri
genera
regul
hcp
phyla
genera
may
benefici
treat
influenza
pcoa
nmd
heatmap
signifi
hcp
may
rebal
intestin
microbiota
prebiot
caus
specif
chang
consumpt
andor
activ
gastrointestin
microbiota
confer
benefit
upon
host
health
remind
us
hcp
serv
prebiot
use
diseas
relat
intestin
dysbacteriosi
chang
function
gene
intestin
microbiom
caus
infect
might
disturb
metabol
nutrient
damag
stabil
intestin
environ
respiratori
pathogen
challeng
probabl
rais
possibl
diseas
disturb
correspond
function
gene
microbiom
hcp
regul
gene
restor
degre
intestin
homeostasi
studi
need
verifi
whether
function
host
effect
influenc
chang
intestin
flora
function
gene
intestin
microbiota
imbal
could
caus
occurr
gut
inflamm
toll
like
receptor
tlr
bind
varieti
microbi
product
recogn
endogen
ligand
mediat
cytokin
secret
immun
respons
disord
microbiota
undesir
chang
bacteri
product
may
stimul
tlr
signal
pathway
experi
express
intestin
infect
mice
significantli
increas
addit
increas
proinflammatori
cytokin
concentr
decreas
antiinflammatori
cytokin
concentr
show
present
result
indic
hcp
markedli
allevi
inflamm
probabl
via
inhibit
tlr
signal
pathway
product
promot
product
consist
find
vitro
macromolecular
substanc
polysaccharid
absorb
directli
blood
reason
treat
diseas
oral
administr
macromolecular
substanc
unabl
use
intraven
hcp
given
oral
may
gain
system
treatment
local
act
intestin
microbiota
may
improv
gut
barrier
damag
might
reduc
bacteri
transloc
moreov
restor
microbiota
homeostasi
help
maintain
intestin
function
modifi
activ
tlr
signal
therebi
cytokin
secret
regul
advers
influenc
intestin
distal
organ
mitig
besid
intestin
microbiota
might
potenti
target
treat
diseas
remot
organ
ribavirin
antivir
drug
commonli
use
clinic
treatment
influenza
form
result
although
ribavirin
effect
reduc
lung
injuri
may
necessarili
benefici
intestin
microbiota
rebal
microbiota
even
reduc
genera
undetect
level
elev
concentr
intestin
hcp
similar
effect
ribavirin
suppress
lung
inflamm
caus
influenza
hcp
restor
gut
microbiota
homeostasi
elev
level
significantli
suggest
hcp
may
superior
ribavirin
maintain
intestin
health
therefor
consid
combin
hcp
ribavirin
may
better
amelior
clinic
symptom
influenza
benefici
recoveri
treatment
provid
new
idea
clinic
treatment
influenza
deserv
explor
hcp
given
oral
allevi
lung
injuri
intestin
dysfunct
caus
infect
hcp
reliev
intestin
barrier
damag
evidenc
inhibit
mucosubst
level
well
restor
express
hcp
restor
intestin
microbiota
homeostasi
regul
composit
divers
rel
abund
function
gene
intestin
microbiota
decreas
tlr
level
increas
concentr
hcp
treatment
contribut
inhibit
inflamm
reason
treat
diseas
oral
administr
macromolecular
substanc
tradit
chines
medicin
unabl
use
intraven
